Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathological response and clinical outcomes in operable triple-negative breast cancer with cisplatin added to standard neoadjuvant chemotherapy.
Georgy JT, Singh A, John AO, Joel A, Andrews AG, Thumaty DB, Rebekah G, Sigamani E, Chandramohan J, Manipadam MT, Cherian AJ, Abraham DT, Paul MJ, Balakrishnan R, Backianathan S, Chacko RT. Georgy JT, et al. Among authors: rebekah g. Klin Onkol. 2021 Winter;34(1):49-55. doi: 10.48095/ccko202149. Klin Onkol. 2021. PMID: 33657819 English.
Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India.
Joel A, Georgy JT, Thumaty DB, John AO, Chacko RT, Rebekah G, Sigamani E, Chandramohan J, Manipadam MT, Cherian AJ, Abraham DT, Jacob PM, Sebastian P, Backianathan S, Singh A. Joel A, et al. Among authors: rebekah g. Ecancermedicalscience. 2021 Mar 19;15:1207. doi: 10.3332/ecancer.2021.1207. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33912232 Free PMC article.
Imaging correlates of serum enzyme-linked immunoelectrotransfer blot (EITB) positivity in patients with parenchymal neurocysticercosis: results from 521 patients.
Vasudevan P, Moorthy RK, Rebekah G, Jackson E, Pamela BE, Thamizhmaran S, Manoj J, Thanigachalam A, Drevets D, Carabin H, Rajshekhar V. Vasudevan P, et al. Among authors: rebekah g. Trans R Soc Trop Med Hyg. 2022 Feb 1;116(2):117-123. doi: 10.1093/trstmh/trab091. Trans R Soc Trop Med Hyg. 2022. PMID: 34157108 Free PMC article.
Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer.
Singh A, Georgy JT, Joel A, Thumaty DB, John AO, Ramnath N, George TK, Sharma P, Patole S, Rebekah G, Sigamani E, Manipadam MT, Cherian AJ, Abraham DT, Paul MJ, Balakrishnan R, Sebastian P, Backianathan S, Chacko RT. Singh A, et al. Among authors: rebekah g. Cancer Invest. 2023 Oct;41(9):789-802. doi: 10.1080/07357907.2023.2278048. Epub 2023 Nov 17. Cancer Invest. 2023. PMID: 37909664
Comparative analysis of mutational patterns in triple negative breast cancer before and after neoadjuvant chemotherapy in patients with residual disease.
Singh A, Georgy JT, Dhananjayan S, Sigamani E, John AO, Joel A, Chandramohan J, Abarna R, Rebekah G, Backianathan S, Abraham DT, Paul MJ, Chacko RT, Manipadam MT, Pai R. Singh A, et al. Among authors: rebekah g. Gene. 2024 Feb 15;895:147980. doi: 10.1016/j.gene.2023.147980. Epub 2023 Nov 10. Gene. 2024. PMID: 37951371
130 results